- Home
- LGND vs PRGO Comparison
LGND vs PRGO Comparison
Compare LGND & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGND
- PRGO
- Stock Information
- Founded
- LGND 1987
- PRGO 1887
- Country
- LGND United States
- PRGO Ireland
- Employees
- LGND 68
- PRGO N/A
- Industry
- LGND Biotechnology: Pharmaceutical Preparations
- PRGO Biotechnology: Pharmaceutical Preparations
- Sector
- LGND Health Care
- PRGO Health Care
- Exchange
- LGND Nasdaq
- PRGO Nasdaq
- Market Cap
- LGND 3.2B
- PRGO 3.1B
- IPO Year
- LGND 1992
- PRGO 1991
- Fundamental
- Price
- LGND $184.44
- PRGO $21.19
- Analyst Decision
- LGND Strong Buy
- PRGO Buy
- Analyst Count
- LGND 8
- PRGO 4
- Target Price
- LGND $144.71
- PRGO $31.25
- AVG Volume (30 Days)
- LGND 139.7K
- PRGO 1.6M
- Earning Date
- LGND 08-05-2025
- PRGO 11-05-2025
- Dividend Yield
- LGND N/A
- PRGO 5.45%
- EPS Growth
- LGND N/A
- PRGO N/A
- EPS
- LGND N/A
- PRGO N/A
- Revenue
- LGND $181,488,000.00
- PRGO $4,326,100,000.00
- Revenue This Year
- LGND $18.41
- PRGO $2.23
- Revenue Next Year
- LGND $18.87
- PRGO $0.54
- P/E Ratio
- LGND N/A
- PRGO N/A
- Revenue Growth
- LGND 53.40
- PRGO N/A
- 52 Week Low
- LGND $81.74
- PRGO $20.52
- 52 Week High
- LGND $129.90
- PRGO $30.93
- Technical
- Relative Strength Index (RSI)
- LGND 58.00
- PRGO 41.41
- Support Level
- LGND $182.87
- PRGO $21.14
- Resistance Level
- LGND $194.44
- PRGO $22.01
- Average True Range (ATR)
- LGND 5.35
- PRGO 0.49
- MACD
- LGND -0.77
- PRGO 0.03
- Stochastic Oscillator
- LGND 40.05
- PRGO 14.20
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
About PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.